Form 4: Inovio Pharmaceuticals Director Wendy Yarno Reports Stock Transactions
SEC Form 4 Filing
Director Wendy Yarno reports the vesting and subsequent disposal of restricted stock units into common stock of Inovio Pharmaceuticals.
Summary
- On May 21, 2025, Wendy Yarno, a director of Inovio Pharmaceuticals, reported transactions involving the company's stock.
- Yarno vested 2,167 restricted stock units, each representing a contingent right to receive one share of common stock.
- Following the vesting, Yarno disposed of 2,167 shares of common stock.
- After these transactions, Yarno beneficially owns 10,512 shares of Inovio Pharmaceuticals.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions by a company director, with no inherent positive or negative implications.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership.
Key Dates
| Date | Description |
|---|---|
| 05/21/2025 | Date of transaction: vesting of restricted stock units and disposal of common stock. |
Keywords
Inovio Pharmaceuticals, Wendy Yarno, Director, Stock, Restricted Stock Units, Beneficial Ownership, Form 4, INO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.